TB Prevention Should Be Delayed Until After Pregnancy in HIV-Infected Women
Safety and efficacy of isoniazid for the prevention of tuberculosis may vary between HIV-infected pregnant and postpartum women.
Safety and efficacy of isoniazid for the prevention of tuberculosis may vary between HIV-infected pregnant and postpartum women.
Mailing human papillomavirus (HPV) self-sampling test kits to underscreened women may increase cervical cancer screening uptake in healthcare systems in the United States.
In a study published in Clinical Infectious Diseases, researchers hypothesized that the underrepresentation of women in HIV intervention trials in the United States may be a result of higher clinical trial screen-out rates in women compared with men. Although they found that screen-out rates did not differ by sex, researchers highlighted that the results underscored…
Maternal efavirenz use tied to increased risk among children who are HIV-exposed but uninfected
Front-line providers minimally could check HBV DNA and ALT during pregnancy to assess mother‐to‐child transmission risk but HBeAg is recommended to be included in the initial HBV evaluation to get a more comprehensive understanding of the patient’s HBV disease state.
In women with HIV, lower education and hepatitis C co-infection are independently associated with the onset of menopause before age 45 years.
Investigators found data from the National Notifiable Diseases Surveillance System that showed hepatitis C virus infection rates doubled among women of reproductive age between 2006 and 2014.
Maternal viremia predicted fetal infection and neonatal outcome of infants of women with a primary cytomegalovirus infection during pregnancy.
No significant difference found in detection of CIN2+ or treatment with intervention versus usual care
The rate of hepatitis C virus infection (HCV) in pregnant women at the time of delivery in the US increased from 0.8 per 1000 live births in 2000 to 4.1 per 1000 in 2015.